Ryan D Maynard's Net Worth
$619 Thousand
Who is Ryan D Maynard?
Ryan D Maynard does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, IOVANCE BIOTHERAPEUTICS, INC., and Cara Therapeutics, Inc..
SEC CIK
Ryan D Maynard's CIK is 0001363984
Past Insider Trading and Trends
2012 was Ryan D Maynard's most active year for acquiring shares with 6 total transactions. Ryan D Maynard's most active month to acquire stocks was the month of May. 2012 was Ryan D Maynard's most active year for disposing of shares, totalling 13 transactions. Ryan D Maynard's most active month to dispose stocks was the month of August. 2012 saw Ryan D Maynard paying a total of $649,012.98 for 250,002 shares, this is the most they've acquired in one year. In 2017 Ryan D Maynard cashed out on 200,000 shares for a total of $390,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$3.02 | -$176,000.00 |
0
|
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4/A
|
—
|
0
|
$8.58 | -$97,330.12 |
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
$8.58 | -$97,330.12 |
0
|
Sep 7 - Sep 12
| |||
Form 4
|
—
|
0
|
$8.52 | -$209,367.38 |
0
|
Sep 7 - Sep 10
| |||
Form 4
|
—
|
0
|
$8.55 | -$7,007.50 |
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Snapshot price: $10.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 7.5K |
$6.75 | $50,587.50 | 7.5K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cara Therapeutics, Inc. (CARA) Snapshot price: $0.3227
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -40.65% | -5.49K |
$0.53 | -$2,908.64 | 8.01K |
Scheduled
|
Feb 8
| ||
Form 4
|
∞
| 13.5K |
—
|
—
| 13.5K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||